Join the Oncology Voice Network. Join for Free
Celebrating 100 Episodes: Top MSL Insights, Career Tips, and Community Gratitude
MSL Podcast Medical Science Liaison Career Progression Emotional Intelligence Networking Strategies

Celebrating 100 Episodes: Top MSL Insights, Career Tips, and Community Gratitude


Share This Article


Summary

In the milestone 100th episode of MSL Talk, Tom Caravela celebrates the journey of the podcast and extends gratitude to the supportive community. Reflecting on the podcast's evolution, Tom quizzes listeners on the most downloaded episode and revisits highlights and essential MSL attributes from the early days. He delves into topics like emotional intelligence, career transitions, and field medical excellence. The episode covers crucial aspects of career progression, market saturation, and effective job search strategies. Tom emphasizes the significance of diversity, networking, and personal growth, concluding with a heartfelt expression of gratitude and a recap of key insights.

Please join me for a very special MSL Talk Podcast milestone.
This episode marks our 100th since we started back on March 27th, 2020.
In this episode, I will offer some fun facts, statistics, and behind-the-scenes information, as well as provide a recap per category.


Special thanks to ALL of my awesome guests over the past 2 years and of course, thank YOU to our listeners throughout the world.

Click for Source
MSL Podcast, Medical Science Liaison, Career Progression, Emotional Intelligence, Networking Strategies

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Podcast
MSL Career Options: The transition from Field Medical to Medical Director
Partner Avatar MSL Talk: Tom Caravela, Josh Corriveau

MSL Career Options: The transition from Field Medical to Medical Director

Article
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials
OVN Avatar Shubham Sharma, J Connor Wells, Wilma M Hopman, Joseph C Del Paggio, Bishal Gyawali, Nazik Hammad, Annette E Hay, Christopher M Booth

Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials

Article
CheckMate-067: Raising the Bar for the Next Decade in Oncology
OVN Avatar Sarah A. Weiss, MD, and Harriet Kluger, MD

CheckMate-067: Raising the Bar for the Next Decade in Oncology

Explore OVN